This story isn’t just about Braelyn.
It’s about the power of patients helping patients.
One message on X changed the trajectory of our daughter’s life. We will always be grateful to everyone who helped us find options when we were told there were none.
He continues to quote (Thakur) If approved, DCVax-L would become the first vaccine for GBM, offering a groundbreaking treatment option and capturing a significant market opportunity.
$NWBO High-Grade Glioma Market Witnesses Strong Momentum During the Forecast Period (2026-2036) with Increasing Clinical Activity and Drug Development | DelveInsight
https://t.co/F5LKeq0LJz
Aparna Thakur, an oncology expert at DelveInsight, said that DCVax-L stands out among emerging vaccines as the only one being investigated for both newly diagnosed and recurrent GBM, showing significant survival benefits in both lines. The company has filed for approval in the UK
@ewarren My choices in life and my work ethic determine my current circumstances. Why should I care who makes more. They don't owe me anything. This is a land of opportunity. I think our government forgot how to be fiscally responsible and instead spend like an irresponsible child.
@HollensbeAmanda I bet you and Braelyn are glad to be back home, surrounded by friends & family and sleep in your own beds! Thank you for sharing such a personal journey. Prayers for strength to endure, healing from treatments and eyes open to capture each special day towards a cure 🙏❤️!